NasdaqGM - Nasdaq Real Time Price USD
Liminatus Pharma, Inc. (LIMN)
6.50
-0.10
(-1.52%)
At close: 4:00:00 PM EDT
6.70
+0.20
+(3.08%)
After hours: 5:52:04 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 29.77M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SABA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 10.29 per share. | Indirect | 8,781,435 | Sep 26, 2023 |
Related Tickers
PBM Psyence Biomedical Ltd.
4.4000
+12.24%
PTIX Protagenic Therapeutics, Inc.
3.2800
-6.55%
ABP Abpro Corporation
0.1650
-19.51%
KLTO Klotho Neurosciences, Inc.
0.2892
+122.46%
NRXS NeurAxis, Inc.
2.2660
-1.48%
APVO Aptevo Therapeutics Inc.
0.3300
-2.94%
VOR Vor Biopharma Inc.
0.1710
+6.88%
OSTX OS Therapies Incorporated
1.8000
-0.55%
JBIO Jade Biosciences, Inc.
7.55
-12.31%
PLRZ Polyrizon Ltd.
0.0126
-55.79%